IDEXX Laboratories (IDXX) net assets (shareholders' equity)

Net assets · fiscal 2025
$1.61B

IDEXX Laboratories (IDXX) had net assets of $1.61B at the end of fiscal 2025 (December 31, 2025). That is 0.6% higher than the $1.60B of fiscal 2024. Figures as of 18 Nov 2026, 19:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$1.61B
Change on fiscal 2024
+0.6%
Growth, 5 years
+20.5% a year
Highest on record
$1.61Bfiscal 2025
Lowest on record
-$108.35Mfiscal 2016
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

IDEXX Laboratories net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 20.5% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.61B in fiscal 2025 and the lowest -$108.35M in fiscal 2016.

History · 18 fiscal years

Net assets by fiscal year

IDEXX Laboratories net assets (shareholders' equity), year by year

IDEXX Laboratories (IDXX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$1.61B 0.6% up
2024$1.60B 7.5% up
2023$1.48B 143.9% up
2022$608.74M 11.8% down
2021$689.99M 9.2% up
2020$632.09M 256.2% up
2019$177.47M—
2018-$9.51M—
2017-$54.11M—
2016-$108.35M—
2015-$84.13M 171.6% down
2014$117.52M 77.3% down
2013$518.19M 18.6% down
2012$636.22M 17.9% up
2011$539.58M 6.0% down
2010$574.24M 11.6% up
2009$514.57M 17.4% up
2008$438.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of IDEXX Laboratories and comparable companies
CompanyNet assetsFiscal year
argenx ARGX$7.32B2025
Edwards Lifesciences EW$10.34B2025
Becton, Dickinson BDX$25.39B2025
IDEXX Laboratories IDXX$1.61B2025
Medline MDLN$10.74B2025
Humana HUM$17.66B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IDXX

IDEXX Laboratories, figure by figure

IDEXX Laboratories (IDXX) overview: price, valuation and scorecardAll health care companies by market value

IDEXX Laboratories net assets (shareholders' equity): questions and answers

What are IDEXX Laboratories's net assets?

IDEXX Laboratories (IDXX) had net assets of $1.61B at the end of fiscal 2025 (December 31, 2025). That is 0.6% higher than the $1.60B of fiscal 2024.

What is the growth rate of IDEXX Laboratories's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 20.5% a year.

What are the highest and lowest net assets figures on record for IDEXX Laboratories?

Across the 18 fiscal years on record (2008–2025), the highest was $1.61B in fiscal 2025 and the lowest -$108.35M in fiscal 2016.

How is IDEXX Laboratories's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For IDEXX Laboratories it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “IDEXX Laboratories (IDXX) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/IDXX/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.